Saldanha Carlota, Freitas Teresa, Silva-Herdade Ana Santos
Institute of Biochemistry, Institute of Molecular Medicine, Faculty of Medicine University of Lisbon, Lisbon, Portugal.
Clin Hemorheol Microcirc. 2018;69(1-2):165-173. doi: 10.3233/CH-189110.
Timolol maleate is a compound used in treatment for reducing increased intra-ocular pressure by limiting aqueous humor production. Decreased erythrocyte deformability (ED), increased activity of erythrocyte acetylcholinesterase (AChE), increased values of nitrosoglutathione (GSNO) and nitic oxide (NO) and decreased plasma levels of NO metabolites, were described in primary open angle glaucoma patients. In healthy human red blood cells (RBCs), timolol is an inhibitor of AChE and induces NO efflux and GSNO efflux from that blood component in lower concentration than those obtained in presence of the natural AChE substrate, acetylcholine (ACh). The signal transduction pathway in RBCs described for NO in dependence of AChE-ACh active complex involves Gi protein, protein tyrosine kinase (PTK like Syk and p53/56Lyn), protein tyrosine phosphatase (PTP) and adenylyl cyclase (AC).The aim of this in vitro study was to verify the effect of timolol maleate in ED, NO efflux and NO derivatives molecules (NOx) like nitrite (NO2-), nitrate (NO3-, peroxynitrite (-ONOO) and GSNO under the presence of PTK, PTP, AC and guanylyl cyclase (GC) enzyme proteins inhibitors.Blood samples from healthy donors were each one divided and were performed aliquots in absence (control aliquots) and presence of timolol or timolol plus each inhibitor and Gi protein uncoupling. No significant differences in erythrocyte NO efflux, GSNO, peroxynitrite, nitrite and nitrate concentrations in response to timolol when compared with the untreated blood samples aliquots were obtained.It was observed an increase in erythrocyte deformability at high shear stresses induced by the simultaneous presence of timolol and band 3 protein dephosphorylation by PTK syk inhibitor. No significant differences where verified in peroxynitrite levels in the blood aliquots in presence of timolol plus each enzyme inhibitor and Gi protein uncoupling in relation to the control aliquots. No variation of GSNO concentration occurs under the presence of timolol and AMGT (PTK lyn inhibitor) besides the significant higher values observed with each one of the other inhibitors. Nitrate concentration increases significantly in all aliquots with timolol plus each one of the inhibitors. The same was observe with nitrite levels with exception of the aliquots with timolol plus AMGT or timolol plus Gi protein uncoupling showing no significant values in relation to the control aliquots.Besides the changes in NO derivative molecules and NO efflux from RBCs obtained in this study with blood samples of healthy donors under the effect of timolol plus each inhibitor of the proteins participants in NO signal transduction mechanism, further analogue studies must be promoted with blood samples of patients with glaucoma or any other inflammatory vascular disease.
马来酸噻吗洛尔是一种用于治疗的化合物,通过限制房水生成来降低眼内压升高。在原发性开角型青光眼患者中,发现红细胞变形性(ED)降低、红细胞乙酰胆碱酯酶(AChE)活性增加、亚硝基谷胱甘肽(GSNO)和一氧化氮(NO)值增加以及血浆中NO代谢产物水平降低。在健康人红细胞(RBC)中,噻吗洛尔是AChE的抑制剂,并且在比天然AChE底物乙酰胆碱(ACh)存在时更低的浓度下诱导该血液成分中NO和GSNO流出。描述了RBC中依赖于AChE - ACh活性复合物的NO信号转导途径涉及Gi蛋白、蛋白酪氨酸激酶(如Syk和p53/56Lyn的PTK样)、蛋白酪氨酸磷酸酶(PTP)和腺苷酸环化酶(AC)。本体外研究的目的是在PTK、PTP、AC和鸟苷酸环化酶(GC)酶蛋白抑制剂存在的情况下,验证马来酸噻吗洛尔对ED、NO流出以及NO衍生物分子(NOx)如亚硝酸盐(NO2-)、硝酸盐(NO³-)、过氧亚硝酸盐(-ONOO)和GSNO的影响。来自健康供体的血样被分别划分,并在不存在(对照等分试样)以及存在噻吗洛尔或噻吗洛尔加每种抑制剂和Gi蛋白解偶联的情况下进行等分试样操作。与未处理的血样等分试样相比,在噻吗洛尔作用下红细胞NO流出、GSNO、过氧亚硝酸盐、亚硝酸盐和硝酸盐浓度没有显著差异。观察到在PTK syk抑制剂同时存在导致带3蛋白去磷酸化以及噻吗洛尔诱导的高剪切应力下红细胞变形性增加。与对照等分试样相比,在存在噻吗洛尔加每种酶抑制剂和Gi蛋白解偶联的血样等分试样中,过氧亚硝酸盐水平没有显著差异。除了与其他每种抑制剂观察到的显著更高值外,在噻吗洛尔和AMGT(PTK lyn抑制剂)存在下GSNO浓度没有变化。在所有含有噻吗洛尔加每种抑制剂的等分试样中硝酸盐浓度显著增加。亚硝酸盐水平也是如此,除了含有噻吗洛尔加AMGT或噻吗洛尔加Gi蛋白解偶联的等分试样与对照等分试样相比没有显著值。除了本研究中在噻吗洛尔加参与NO信号转导机制的每种蛋白质抑制剂作用下,从健康供体血样获得的RBC中NO衍生物分子和NO流出的变化外,必须用青光眼患者或任何其他炎症性血管疾病患者的血样进一步开展类似研究。